DOI: 10.1128/mBio.00420-19
Article Information
PubMed
Published By
History
- Received February 15, 2019
- Accepted April 22, 2019
- Published online May 28, 2019.
Copyright & Usage
Copyright © 2019 Bernabeu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Editors and / or Reviewers
- L. David Sibley, Editor, Washington University School of Medicine
Author Information
- Maria Bernabeua,
- Celina Gunnarssonb*,
- Maria Vishnyakovaa,
- Caitlin C. Howardb,
- Ryan J. Nagaob,
- Marion Avrila,
- Terrie E. Taylorc,d,
- Karl B. Seydelc,d,
- Ying Zhengb,e,
- Joseph D. Smitha,f
- aSeattle Children’s Research Institute, Seattle, Washington, USA
- bDepartment of Bioengineering, University of Washington, Seattle, Washington, USA
- cBlantyre Malaria Project, University of Malawi College of Medicine, Blantyre, Malawi
- dDepartment of Osteopathic Medical Specialties, College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, USA
- eCenter for Cardiovascular Biology, Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington, USA
- fDepartment of Global Health, University of Washington, Seattle, Washington, USA
- Address correspondence to Ying Zheng, yingzy{at}uw.edu, or Joseph D. Smith, joe.smith{at}seattlechildrens.org.
↵* Present address: Celina Gunnarsson, Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA.
M.B. and C.G. contributed equally to this article.
Citation Bernabeu M, Gunnarsson C, Vishnyakova M, Howard CC, Nagao RJ, Avril M, Taylor TE, Seydel KB, Zheng Y, Smith JD. 2019. Binding heterogeneity of Plasmodium falciparum to engineered 3D brain microvessels is mediated by EPCR and ICAM-1. mBio 10:e00420-19. https://doi.org/10.1128/mBio.00420-19.
